Towards Healthcare
Molecular Diagnostics Market Trends | Growth | Analysis

Molecular Diagnostics Market Size Envisioned at USD 25.27 Billion by 2032

The report covers Molecular Diagnostics Market Size and Companies such as BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Abbott, Agilent Technologies, Inc., Danaher, Hologic Inc. (Gen Probe), Illumina, Inc., Grifols, S.A., QIAGEN, F. Hoffmann-La Roche, Ltd., Siemens Healthineers AG and Sysmex Corporation. Segmented by Product Type, Technology, Test Location, Application and Geography. These segments offer a comprehensive understanding of the market dynamics and cater to various needs within the healthcare sector. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Molecular Diagnostics Market Assessment

  • Overview
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Molecular Diagnostics Market Assessment

  • Overview
  • North America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • North America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • North America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • North America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

Europe Molecular Diagnostics Market Assessment

  • Overview
  • Europe Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • Europe Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • Europe Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • Europe Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

Asia Pacific Molecular Diagnostics Market Assessment

  • Overview
  • Asia Pacific Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • Asia Pacific Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • Asia Pacific Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • Asia Pacific Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

Middle East and Africa Molecular Diagnostics Market Assessment

  • Overview
  • Middle East and Africa Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • Middle East and Africa Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • Middle East and Africa Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • Middle East and Africa Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

South America Molecular Diagnostics Market Assessment

  • Overview
  • South America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • South America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • South America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • South America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

Company Profiles

  • BD
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Agilent Technologies, Inc.
  • Danaher
  • Hologic Inc. (Gen Probe)
  • Illumina, Inc.
  • Grifols, S.A.
  • QIAGEN
  • F. Hoffmann-La Roche, Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation

Conclusion & Recommendations

  • Insight Code: 5150
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: April 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a dedicated market research professional with over 2 years of experience in the healthcare industry. Specializing in healthcare market research, she brings valuable expertise in analyzing market trends, evaluating industry dynamics, and providing actionable insights to help businesses stay ahead in a competitive market.

Throughout her career, Deepa has focused on delivering in-depth research on various healthcare segments, including pharmaceuticals, biotechnology, and healthcare services. She excels in identifying emerging opportunities, assessing market risks, and understanding regulatory changes that impact the healthcare sector.

Her ability to synthesize complex data and translate it into clear, concise recommendations makes her a key contributor to successful strategic decision-making. Her work helps organizations better understand consumer behavior, market demands, and the regulatory landscape, facilitating informed business strategies.

With a passion for healthcare research and a commitment to excellence, Deepa continues to provide businesses with the market intelligence they need to thrive in an increasingly complex healthcare environment. Her insights are critical for companies seeking to navigate the evolving healthcare landscape and optimize their market positioning.

FAQ's

Stringent regulatory processes for approval of new diagnostic tests, high initial investment costs for advanced technologies, and reimbursement limitations in certain regions pose challenges to market growth. Additionally, ensuring the accessibility of these tests in resource-limited settings requires innovative solutions.

Focusing on developing innovative and cost-effective diagnostic solutions, strategic partnerships with healthcare providers and laboratories, expanding into emerging markets, and actively participating in research and development to stay ahead of the competition are key strategies for success in the molecular diagnostics market. Additionally, ensuring compliance with regulatory requirements and advocating for favorable reimbursement policies are crucial aspects.

Advancements in technologies like next-generation sequencing (NGS), digital PCR, microfluidics, and CRISPR hold immense potential for the molecular diagnostics market. These innovations offer greater sensitivity, specificity, faster turnaround times, and the ability to perform multiplex testing for multiple targets simultaneously, leading to more comprehensive and efficient diagnostics.

The U.S. Food and Drug Administration, KFF (Kaiser Family Foundation), World Health Organization, National Institute of Health and Centers for Disease Control and Prevention.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515